Ocugen OCGN
NASDAQ OCGN
$1.36 +0.01 (+0.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

Ocugen (OCGN) Income towards Parent Company (2014 - 2026)

Ocugen's (OCGN) quarterly Income towards Parent Company came in at -$35.9 million in Q1 2026, down 131.98% YoY from $112.1 million in Q1 2025, and down 98.84% on a QoQ basis from -$18.0 million in Q4 2025.

Analysis

Ocugen (OCGN) Income towards Parent Company (2014 - 2026) Analysis & Trends

Ocugen (OCGN) has 13 years of Income towards Parent Company data on file, last reported at -$35.9 million in Q1 2026.

  • Quarterly Income towards Parent Company fell 131.98% year-over-year to -$35.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$92.8 million (down 46.4% YoY) and the FY2025 annual result came in at -$198.0 million, down 14.43% from the prior year.
  • Income towards Parent Company fell to -$35.9 million in Q1 2026, from -$18.0 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of -$13.0 million in Q3 2024 to a low of -$123.9 million in Q4 2023.
  • A 5-year average of -$27.7 million and a median of -$21.0 million in 2024 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2023 — Income towards Parent Company slumped 464.92% — and 2024, when it jumped 88.75%.
  • Tracing OCGN's Income towards Parent Company over 5 years: stood at -$21.9 million in 2022, then tumbled by 464.92% to -$123.9 million in 2023, then jumped by 88.75% to -$13.9 million in 2024, then declined by 29.36% to -$18.0 million in 2025, then slumped by 98.84% to -$35.9 million in 2026.
  • The last three Income towards Parent Company figures came in at -$35.9 million (Q1 2026), -$18.0 million (Q4 2025), and -$18.7 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Ocugen 458.91 Mn 358.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -20.52 Mn
Mar 31, 2026 -19.03 Mn
Dec 31, 2025 -18.21 Mn
Sep 30, 2025 -18.73 Mn
Jun 30, 2025 -14.85 Mn
Mar 31, 2025 -15.42 Mn
Dec 31, 2024 -13.98 Mn
Sep 30, 2024 -12.97 Mn
Jun 30, 2024 -15.28 Mn
Mar 31, 2024 -11.91 Mn
Dec 31, 2023 -11.53 Mn
Sep 30, 2023 -12.43 Mn
Jun 30, 2023 -23.54 Mn
Mar 31, 2023 -18.04 Mn
Dec 31, 2022 -21.94 Mn
Sep 30, 2022 -21.92 Mn
Jun 30, 2022 -21.58 Mn
Mar 31, 2022 -19.03 Mn
Dec 31, 2021 -14.58 Mn
Sep 30, 2021 -10.76 Mn